Resources
Webinars
2021 智慧醫療及照護高峰論壇|跨域推進 智慧醫療再進化【Trend Forum】 October 15, 2021
2021 智慧醫療及照護高峰論壇|跨域推進 智慧醫療再進化【Trend Forum】 October 15, 2021
News
19 August 2022
Atgenomix is Now an HL7 Gold Member
As a Gold Member in Health Level Seven International (HL7), Atgenomix supports the HL7 objective to create a suite of standard-based technologies for streamlining sophisticated data management and computational analysis of biomedical and multi-omics information.
16 May 2022
Atgenomix Staff Scientist Joins Virtual Symposium for Dentists
Yin-Hung Lin, Ph.D. presented and discussed how a unified bioinformatics platform can empower the precision medicine industry in the application of digital transformation to face the challenges of paradigm shift in dentistry and medicine, in particular oral cancer genomics.
1 April 2022
The Future of Precision Medicine
Allen joins Science Monthly as a guest contributor, sharing how biomedical information technology drives the future of precision medicine.
Collaborative Publications
Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine
Machine-learning optimized long-range genome analysis workflow for next-generation sequencing
Accelerating String Graph Construction for De Novo Assembly on Spark
An integrated platform for cohort-based annotation and interpretation of genetic variants on Spark
Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank
DeepVariant-on-Spark: Small-Scale Genome Analysis Using a Cloud-Based Computing Framework
Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes BSN and PCLO in Schizophrenia and Bipolar Disorder
Identification of a novel nonsense homozygous mutation of LINS1 gene in two sisters with intellectual disability, schizophrenia, and anxiety
Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients with Schizophrenia
Involvement of Rare Mutations of SCN9A, DPP4, ABCA13, and SYT14 in Schizophrenia and Bipolar Disorder